US Stock MarketDetailed Quotes

RDY Dr. Reddy's Laboratories

Watchlist
  • 15.370
  • +0.250+1.65%
Close Dec 20 16:00 ET
  • 15.270
  • -0.100-0.65%
Post 20:01 ET
12.80BMarket Cap20.44P/E (TTM)

Dr. Reddy's Laboratories Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Dr. Reddy's Laboratories Q2 2025 Earnings Date

Currency：INRNov 5, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
76.93B
80.16B
+3.23B
Beat Est.
+11.81%
+16.51%
+4.20%
EPS
--
3.01
--
-15.26%
Analyst Rating
Buy

Nov 6, 2024

Dr. Reddy's Laboratories Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: INR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 82.563B--
--2025/Q3-- / 82.687B--
Nov 5, 20242025/Q280.162B / 76.929B--
Jul 27, 20242025/Q176.727B / 72.711B--
May 7, 20242024/Q471.138B / 70.210B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 82.563B--
--2025/Q3-- / 82.687B--
Nov 5, 20242025/Q280.162B / 76.929B--
Jul 27, 20242025/Q176.727B / 72.711B--
May 7, 20242024/Q471.138B / 70.210B--

Unlock Free Earnings Estimates

Dr. Reddy's Laboratories Earnings Reports

  • Dr. Reddy's Laboratories | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 6 06:17 ET

  • Dr. Reddy's Laboratories | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 5 14:16 ET

  • Dr. Reddy's Laboratories | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 5 13:46 ET

  • Dr Reddy's Laboratories Ltd | 6-K: Report of foreign private issuer (related to financial reporting)

    Jul 29 14:30 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 6, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Infectious Disease
    Infectious Disease
    Intraday+0.78%